Rockwell Medical, Inc.
RMTI
$0.80
-$0.04-4.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.72% | -205.35% | -534.99% | 12.48% | 50.00% |
| Total Depreciation and Amortization | 0.55% | 0.18% | 2.55% | -1.10% | -1.27% |
| Total Amortization of Deferred Charges | 0.00% | 1.14% | 193.33% | -59.82% | -89.29% |
| Total Other Non-Cash Items | -20.83% | -20.18% | 26.09% | 47.92% | 64.55% |
| Change in Net Operating Assets | 28,520.00% | -230.60% | 1,047.62% | -71.23% | 100.98% |
| Cash from Operations | 164.86% | -130.57% | 27.88% | -46.51% | 2,111.63% |
| Capital Expenditure | 78.23% | -19.90% | 42.66% | 54.68% | -818.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,520.63% | 31.09% | -96.95% | -- | -96.93% |
| Cash from Investing | -1,144.28% | 29.50% | -106.00% | 99.28% | -116.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 9.91% | 5.57% | -55.80% | 9.16% | 81.74% |
| Issuance of Common Stock | -100.00% | 115.32% | -- | -- | 244.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.85% | 23.16% | -- | -- | -1,818.42% |
| Cash from Financing | -137.93% | 191.57% | -131.48% | -539.89% | 476.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -187.21% | 137.47% | -79.10% | -82.44% | 171.57% |